Paolo Bonanni, Angela Bechini, Rosa Donato, Raffaella Capei, Cristiana Sacco, Miriam Levi, Sara Boccalini
Human papilloma virus (HPV) vaccination has been implemented in several countries for about the past 7 years, mainly in the adolescent female population, with varying coverage results. Although the impact of immunization on cervical and other HPV-related cancers will be evident in the next decades, a marked decrease of prevalent HPV infections, precancerous lesions and genital warts is already dramatic in the vaccinated cohorts, and also in their sexual partners, thus providing clear evidence of the effectiveness of HPV vaccination, including a herd-protection effect...
January 2015: Therapeutic Advances in Vaccines